Eli Lilly and Company (NYSE: LLY) today announced detailed results from QWINT-1, QWINT-3, and QWINT-4 Phase 3 clinical trials evaluating the safety and efficacy of investigational once-weekly insulin efsitora alfa (efsitora) in adults with type 2 diabetes who used insulin for the first
Trials
The 2024 UCI Urban Cycling World Championships wrapped up in spectacular fashion in Abu Dhabi, United Arab Emirates, with a week of exhilarating competition across trials and BMX Freestyle disciplines. The five-day event drew athletes from around the world, each competing for the coveted rainbow jerseys, and concluded with awe-inspiring performances that left spectators











